Quisel John D
SEC CIK 1586788 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IRON | Disc Medicine, Inc. | CEO, Dir | 262.1K | — | $17.45M | 29 | 2023-12-29 | 2026-09-15 |
Most active insiders at IRON, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | AI DMI LLC | 10% | — | $59.87M |
| 2 | Bitterman Kevin | Dir | — | $37.69M |
| 3 | Quisel John D | CEO, Dir | — | $12.03M |
| 4 | Yu Jonathan Yen-Wen | COO | — | $5.59M |
| 5 | Savage William Jacob | Chief Medical Off | — | $2.27M |
| 6 | Khara Rahul | CLO | — | $1.87M |
| 7 | Franchi Jean M. | CFO | — | $1.20M |
| 8 | Stephenson Pamela | Chief Commercial Off | — | $347.7K |
Transactions 29
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-16 18:44 | 2026-09-15 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | M - OptEx | $1.01 | +36.0K | 262.1K | +16% | +$36.4K |
| DT | 2026-08-18 18:56 | 2026-08-17 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | M - OptEx | $13.50 | +33.0K | 259.1K | +15% | +$445.5K |
| DMT | 2026-08-18 18:56 | 2026-08-17 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | S - Sale+OE | $79.15 | -33.0K | 226.1K | -13% | -$2.61M |
| DMT | 2026-07-14 18:32 | 2026-07-13 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | M - OptEx | $10.68 | +33.0K | 259.1K | +15% | +$352.4K |
| DMT | 2026-07-14 18:32 | 2026-07-13 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | S - Sale+OE | $74.96 | -33.0K | 226.1K | -13% | -$2.47M |
| DT | 2026-06-23 17:16 | 2026-06-18 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | M - OptEx | $9.86 | +34.0K | 260.1K | +15% | +$335.2K |
| DMT | 2026-06-23 17:16 | 2026-06-18 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | S - Sale+OE | $70.21 | -34.0K | 226.1K | -13% | -$2.39M |
| 2026-02-17 | 2026-02-17 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | S - Sale | $62.86 | -13.3K | 226.1K | -6% | -$833.8K | |
| D | 2026-02-11 | 2026-02-10 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | A - Grant | $0.00 | +55.2K | 239.3K | +30% | $0 |
| D | 2025-12-19 | 2025-12-19 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | M - OptEx | $1.01 | +12.3K | 184.1K | +7% | +$12.4K |
| DT | 2025-12-15 | 2025-12-11 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | M - OptEx | $9.86 | +40.0K | 211.8K | +23% | +$394.4K |
| DMT | 2025-12-15 | 2025-12-11 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | S - Sale+OE | $93.05 | -40.0K | 171.8K | -19% | -$3.72M |
| D | 2025-09-11 | 2025-09-09 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | M - OptEx | $1.01 | +10.0K | 171.8K | +6% | +$10.1K |
| DT | 2025-07-11 | 2025-07-09 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | M - OptEx | $9.86 | +34.8K | 196.6K | +22% | +$343.1K |
| DMT | 2025-07-11 | 2025-07-09 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | S - Sale+OE | $55.33 | -34.8K | 161.8K | -18% | -$1.93M |
| DT | 2025-07-08 | 2025-07-03 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | M - OptEx | $9.86 | +5,200 | 167.0K | +3% | +$51.3K |
| DT | 2025-07-08 | 2025-07-03 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | S - Sale+OE | $55.09 | -5,200 | 161.8K | -3% | -$286.5K |
| D | 2025-04-08 | 2025-04-07 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | M - OptEx | $1.01 | +7,000 | 161.8K | +5% | +$7,070 |
| 2025-02-20 | 2025-02-18 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | S - Sale | $54.58 | -5,574 | 154.8K | -3% | -$304.2K | |
| D | 2025-02-12 | 2025-02-10 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | A - Grant | $0.00 | +78.3K | 160.4K | +95% | $0 |
| DMT | 2025-01-02 | 2024-12-30+ | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | M - OptEx | $6.01 | +23.0K | 85.1K | +37% | +$138.4K |
| DMT | 2025-01-02 | 2024-12-30 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | S - Sale+OE | $61.95 | -13.0K | 74.0K | -15% | -$806.1K |
| DMT | 2024-12-26 | 2024-12-23 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | S - Sale+OE | $63.14 | -19.8K | 88.5K | -18% | -$1.25M |
| DT | 2024-12-26 | 2024-12-23 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | M - OptEx | $2.65 | +19.8K | 91.9K | +28% | +$52.5K |
| DT | 2024-12-18 | 2024-12-16 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | M - OptEx | $1.01 | +12.8K | 84.9K | +18% | +$12.9K |
| DMT | 2024-12-18 | 2024-12-16 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | S - Sale+OE | $66.01 | -12.8K | 78.9K | -14% | -$844.3K |
| D | 2024-07-10 | 2024-07-08 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | M - OptEx | $1.01 | +3,000 | 72.1K | +4% | +$3,030 |
| D | 2024-03-01 | 2024-01-10 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | A - Grant | $0.00 | +66.4K | 69.1K | +2,458% | $0 |
| D | 2024-01-03 | 2023-12-29 | IRON | Disc Medicine, Inc. | Quisel John D | CEO, Dir | M - OptEx | $1.01 | +2,700 | 2,700 | New | +$2,727 |
Purchase Sale Sale after option exercise All abbreviations